BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 21419811)

  • 21. Dissociation of epidermal growth factor receptor and ErbB2 heterodimers in the presence of somatostatin receptor 5 modulate signaling pathways.
    Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
    Endocrinology; 2011 Mar; 152(3):931-45. PubMed ID: 21190959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
    Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
    Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.
    El Sheikh SS; Domin J; Abel P; Stamp G; Lalani el-N
    Neoplasia; 2004; 6(6):846-53. PubMed ID: 15720812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidermal growth factor competes with EGF receptor inhibitors to induce cell death in EGFR-overexpressing tumor cells.
    Song JY; Lee SW; Hong JP; Chang SE; Choe H; Choi J
    Cancer Lett; 2009 Oct; 283(2):135-42. PubMed ID: 19380191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.
    Zhou Y; Li S; Hu YP; Wang J; Hauser J; Conway AN; Vinci MA; Humphrey L; Zborowska E; Willson JK; Brattain MG
    Cancer Res; 2006 Jan; 66(1):404-11. PubMed ID: 16397255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
    Kharmate G; Rajput PS; Watt HL; Somvanshi RK; Chaudhari N; Qiu X; Kumar U
    Biochim Biophys Acta; 2011 Jun; 1813(6):1172-89. PubMed ID: 21419811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The roles of phospholipase D in EGFR signaling.
    Lee CS; Kim KL; Jang JH; Choi YS; Suh PG; Ryu SH
    Biochim Biophys Acta; 2009 Sep; 1791(9):862-8. PubMed ID: 19410013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Signal transduction mechanisms induced by epidermal growth factor receptor (EGFR) and their role in apoptosis regulation].
    Ołdak M; Malejczyk J
    Postepy Hig Med Dosw; 1999; 53(2):315-29. PubMed ID: 10355296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-talk and modulation of signaling between somatostatin and growth factor receptors.
    Kumar U
    Endocrine; 2011 Oct; 40(2):168-80. PubMed ID: 21870170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of EGF Receptor Regulatory Networks in the Host Response to Viral Infections.
    Carlin CR
    Front Cell Infect Microbiol; 2021; 11():820355. PubMed ID: 35083168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple positive and negative regulators of signaling by the EGF-receptor.
    Moghal N; Sternberg PW
    Curr Opin Cell Biol; 1999 Apr; 11(2):190-6. PubMed ID: 10209155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatostatin and Somatostatin Receptors in Tumour Biology.
    Kumar U
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caught in the "Akt": Cross-talk between EphA2 and EGFR through the Akt-PIKfyve axis maintains cellular sensitivity to EGF.
    Shi X; Wang B
    Sci Signal; 2018 Jul; 11(541):. PubMed ID: 30065027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions.
    Lezama R; Díaz-Téllez A; Ramos-Mandujano G; Oropeza L; Pasantes-Morales H
    Neurochem Res; 2005 Dec; 30(12):1589-97. PubMed ID: 16362778
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.